Skip to main content
. 2021 Nov 19;115:62–69. doi: 10.1016/j.ijid.2021.11.025

Table 2.

Statistical and RT-PCR negativity summary of Mild-Asymptomatic patients recruited in the clinical trial (n=82)

RT-PCR test Day (negative) Placebo (n=42) (%) Umifenovir (n=40) (%) Diff (%) P value
5 17 (40) 29 (73) 32 0.002
7 29 (69) 31 (78) 8 0.194
9 33 (79) 36 (90) 11 0.078
11 39 (93) 37 (93) 0 0.475
13 41 (98) 39 (98) 0 0.486
15 41 (98) 40 (100) 2 0.163
17 41 (98) 40 (100) 2 0.163
19 42 (100) 40 (100) 0 -